Join
Live feed
·
PRReleasevia Quantisnow
Mereo BioPharma Group plc logo
Neurocrine Biosciences Inc. logo

4basebio Announces Appointment of Chief Financial Officer and Board Changes

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track MREO (Mereo BioPharma Group plc), NBIX (Neurocrine Biosciences Inc.) and more on Quantisnow.

4basebio Announces Appointment of Chief Financial Officer and Board Changes | Quantisnow